2018
DOI: 10.4155/fsoa-2018-0060
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in the Discovery of Small-Molecule Inhibitors of HIV-1 Integrase

Abstract: AIDS caused by the infection of HIV is a prevalent problem today. Rapid development of drug resistance to existing drug classes has called for the discovery of new targets. Within the three major enzymes (i.e., HIV-1 protease, HIV-1 reverse transcriptase and HIV-1 integrase [IN]) of the viral replication cycle, HIV-1 IN has been of particular interest due to the absence of human cellular homolog. HIV-1 IN catalyzes the integration of viral genetic material with the host genome, a key step in the viral replicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
63
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(63 citation statements)
references
References 139 publications
0
63
0
Order By: Relevance
“…In the same way, ring extension at the nitrogen of piperazine was carried out by substituted benzoic acid. The ester linkage in intermediate compound (COOCH3) is hydrolyzed to a carboxylic acid (COOH) in an alkaline medium in the attendance of melted lithium hydroxide to yield the target compounds [1][2][3][4][5][6][7][8][9][10][11][12][13][14] .…”
Section: Chemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…In the same way, ring extension at the nitrogen of piperazine was carried out by substituted benzoic acid. The ester linkage in intermediate compound (COOCH3) is hydrolyzed to a carboxylic acid (COOH) in an alkaline medium in the attendance of melted lithium hydroxide to yield the target compounds [1][2][3][4][5][6][7][8][9][10][11][12][13][14] .…”
Section: Chemistrymentioning
confidence: 99%
“…HIV-1 IN process the integration of viral genetic material with the host genome, a key step in the viral duplication process. Several novel classes of HIV IN inhibitors have been explored by targeting different sites on the enzyme 3,4 .…”
mentioning
confidence: 99%
“…Designing and development of small molecule‐based antimicrobial agents is the need of the day as the microbial disease threat and drug resistance of microbes getting increased. Advanced bioinformatics and biotechnological applications and relevant developments are boosting the discovery and development of small‐molecule drugs effectively . These biologically active compound screening measures are favoring in choosy and effective medicinal agents towards many diseases with agreeable or lesser side effects.…”
Section: Introductionmentioning
confidence: 99%
“…Advanced bioinformatics and biotechnological applications and relevant developments are boosting the discovery and development of small-molecule drugs effectively. [1,2] These biologically active compound screening measures are favoring in choosy and effective medicinal agents towards many diseases with agreeable or lesser side effects. Among a number of small molecules, quinoline-based compounds are getting their attraction in drug designing research studies due to their drug efficacy against a wide range of diseases.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, a number of triterpene derivatives, caffeoylquinic acid derivatives, and flavonoids have exhibited potent inhibitory effects against human immunodeficiency virus (HIV)-1 integrase and prevented HIV-1 replication in tissue culture [15][16][17][18][19]. However, in vitro binding and inhibition of HIV-1 integrase does not always translate into potency against HIV replication [20,21]. In this study, we isolated and characterized nine compounds from the acid hydrolysate of the flower buds of L. fulvotomentosa Hsu et S. C. Cheng and evaluated their respective anti-HIV-protease activity under in vitro conditions, aiming to verify whether inhibition of HIV protease is also involved in the anti-HIV function of Lonicera species.…”
mentioning
confidence: 99%